Clinical Trials Browser

Phase 2 × Rectal Neoplasms × MK 2206 × Clear all

NCT01802320 2019-09-20

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Phase 2 Completed

18 enrolled 7 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01186705 2015-11-18

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Phase 2 Terminated

1 enrolled 4 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms